Another report showed increased DPP4 mRNA levels in NAFLD vs. no-NAFLD patients; however, in this study, NAFLD individuals had significantly higher BMI than normal-liver participants and, therefore, an influence of total fat mass in the relationship between hepatic DPP4 and NAFLD could not be ruled out [14]. This evidence concerns the gene DPP4 and metabolic dysfunction-associated steatotic liver disease.